...
首页> 外文期刊>Journal of Gastrointestinal Oncology >Prognostic factors and hazard ratios in colorectal cancer patients over 80 years of age: a retrospective, 20-year, single institution review
【24h】

Prognostic factors and hazard ratios in colorectal cancer patients over 80 years of age: a retrospective, 20-year, single institution review

机译:80岁以上结直肠癌患者的预后因素和危险比:回顾性,20年单机构审查

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: An aging population and a high incidence of colorectal cancer (CRC) in patients over the age of 80 make it important to understand survival times, hazard ratios and prognostic factors in this group. A better understanding of these factors will help clinicians determine appropriate therapeutic strategies for such patients, including when more aggressive treatment strategies may be preferred to palliative treatment. Methods: A retrospective analysis of 619 CRC patients of ≥80 years of age from 1991–2010 at Baylor Scott & White Hospital in Temple, Texas. Twelve variables were analyzed through statistical analysis as potential prognostic factors for survival. Univariate and multivariate Cox proportional hazard models were used to determine hazard ratios. The elderly population was further stratified by age subgroup (80–84, 85–89, ≥90). Results: Median survival time was 53.6, 30.0, and 11.3 months for age groups of 80–84, 85–89, and ≥90, respectively. Median survival time for stage 0/I, II, III, and IV patients was 72.4, 53.5, 28.0, and 5.9 months, respectively. Patients not receiving surgery had significantly higher mortality (hazard ratio 2.605; 95% CI, 1.826–3.694). For stage III CRC patients, those not receiving chemotherapy had significantly higher mortality (hazard ratio 1.808; 95% CI, 1.018–1.827). Conclusions: Our study provides evidence to support the benefits of surgery and chemotherapy (for stage III) patients over 80, potentially contributing to improved clinical decisions in treating elderly CRC patients. Such patients are sometimes undertreated due to their underrepresentation in clinical trials. Additional prospective studies with a higher proportion of patients over 80 are needed.
机译:背景:人口老龄化和80岁以上的大肠癌(CRC)发病率很高,因此了解该组患者的生存时间,危险比和预后因素非常重要。对这些因素的更好理解将有助于临床医生为此类患者确定适当的治疗策略,包括何时可能选择更积极的治疗策略而非姑息治疗。方法:回顾性分析1991年至2010年在德克萨斯州坦普尔的贝勒斯科特怀特医院的619例≥80岁的CRC患者。通过统计分析分析了十二个变量,作为生存的潜在预后因素。使用单变量和多变量Cox比例风险模型来确定风险比率。老年人群按年龄分组进一步分层(80-84、85-89,≥90)。结果:80-84岁,85-89岁和90岁以上年龄组的中位生存时间分别为53.6、30.0和11.3个月。 0 / I,II,III和IV期患者的中位生存时间分别为72.4、53.5、28.0和5.9个月。未接受手术的患者死亡率显着较高(危险比2.605; 95%CI,1.826–3.694)。对于III期CRC患者,未接受化疗的患者死亡率更高(危险比1.808; 95%CI为1.018-1.827)。结论:我们的研究提供了证据支持80岁以上的手术和化疗(对于III期患者)的益处,可能有助于改善老年CRC患者的临床决策。由于此类患者在临床试验中的代表性不足,因此有时会受到治疗不足。需要对80岁以上的患者比例更高的其他前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号